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Abstract 
Type 2 diabetes is the most common metabolic disorder today and has reached 
epidemic proportions in many countries. Diet-induced insulin resistance plays a 
central role in the development of type 2 diabetes. Studies included in this thesis 
describe findings regarding two forkhead genes, Foxf2 and Foxc2, and their 
involvement in the development of insulin resistance. We produced a mouse in 
which the forkhead factor FOXF2 is overexpressed in an adipose tissue-restricted 
fashion, such mice display induced insulin secretion in response to an intravenous 
glucose load. In addition we could demonstrate that adipocytes from FOXF2 
transgenic mice have an impaired insulin-mediated glucose uptake. We argue this to 
be, at least in part, due to lower expression of insulin receptor substrate 1. Mice 
overexpressing forkhead factor FOXC2 in adipose tissue have previously been 
shown to be protected from diet-induced obesity and glucose intolerance. In 
hyperinsulinemic-euglycemic clamp experiments, we demonstrated that FOXC2 
transgenic mice are protected from diet-induced insulin resistance in liver and 
skeletal muscle. Furthermore, on high-fat diet, FOXC2 transgenic mice displayed 
decreased intramuscular levels of fatty acyl CoA compared with wild-type 
littermates. Expansion and regression of adipose tissue requires continuous 
remodelling of the vasculature in order to meet demands of metabolism. We have 
shown that the adipose tissue of FOXC2 transgenic mice exhibit a higher vascular 
density and altered pattering of vascular smooth muscle cells and pericytes. 
Furthermore, we could show this, at least in part, to be dependent on the role of 
FOXC2 as a direct regulator of Angiopoietin 2. 
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